Comvita Limited — Director's Dealing 2019

Sep 6, 2019

==> picture [91 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and Name of listed issuer: Date this disclosure made: Date of last disclosure:

Director or senior manager giving disclosure

Full name(s): Name of listed issuer: Name of related body corporate (if applicable): Position held in listed issuer:

Comvita Limited 6-Sep-19 2-Sep-19 Julianne Marie Keast Comvita Limited n/a Acting Chief Financial Officer

	on held in listed issuer:Acting Chief Financial Officer	on held in listed issuer:Acting Chief Financial Officer	on held in listed issuer:Acting Chief Financial Officer	on held in listed issuer:Acting Chief Financial Officer
Sum	mary of acquisition or disposal of relevant interest (excluding specified derivatives)
	of affected quoted financial products:
Class	of affected quoted financial products:		Ordinary Shares
Natur
	e of the affected relevant interest(s):		Registered holder
For t	hat relevant interest-
Numb	er held in class before acquisition or disposal:		Julianne Marie Keast - 44,954Craigs Start Scheme A/C-8,686
Numb	er held in class after acquisition or disposal:		Julianne Marie Keast - 57,873Craigs Start Scheme A/C-8,686
Curre	nt registered holder(s):		Julianne Marie Keast
Regis	tered holder(s) once transfers are registered:		Same as current registered holders
	ls of transactions giving rise to acquisition or disposal
Total
	number of transactions to which notice relates:

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: Details of transactions requiring disclosure- Date of transaction: Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related:

1 5-Sep-19 Purchase of 12,919 shares on market N/A $34,112 1 No n/a n/a

If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal to		n/a
proceed duringthe closedperiod:
Date of the prior written clearance (if any):		n/a

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature:

==> picture [93 x 27] intentionally omitted <==

6-Sep-19